Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BHST
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
proactiveinvestors.com
8 hours ago
proactiveinvestors.com
8 hours ago
newsfilecorp.com
8 hours ago
seekingalpha.com
19 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
N/A
-0.13
vs -0.30
Q4.23
N/A
-0.54
vs -0.21
Q1.24
N/A
-0.48
vs -0.06
Q2.24
N/A
-0.04
vs -0.21
Q3.24
N/A
-0.16
vs -0.13
Q4.24
N/A
-0.17
vs -0.54
Q1.25
N/A
-0.13
vs -0.48
Q2.25
N/A
-0.15
vs -0.04
Q3.25
N/A
-0.12
vs -0.16
Q4.25
N/A
-0.08
vs -0.17
Sales Growth
YoY
Current
Estimates
Q3.23
+114%
3.2M vs 1.5M
Q4.23
+85%
4.5M vs 2.4M
Q1.24
+147%
5.3M vs 2.2M
Q2.24
+119%
6M vs 2.8M
Q3.24
+102%
6.5M vs 3.2M
Q4.24
+61%
7.3M vs 4.5M
Q1.25
+47%
7.8M vs 5.3M
Q2.25
+41%
8.5M vs 6M
Q3.25
+39%
9.1M vs 6.5M
Q4.25
+43%
10.4M vs 7.3M
Return on Equity
QoQ
Q1.23
+15%
0.15
vs 0.47
Q2.23
+46%
0.46
vs 0.15
Q3.23
+22%
0.22
vs 0.46
Q4.23
+49%
0.49
vs 0.22
Q1.24
+207%
2.07
vs 0.49
Q2.24
-10%
-0.10
vs 2.07
Q3.24
-65%
-0.65
vs -0.10
Q4.24
-222%
-2.22
vs -0.65
Q1.25
+266%
2.66
vs -2.22
Q2.25
+97%
0.97
vs 2.66
Institutionnal Ownership
N/A
Q3.23
NA
NA
vs NA
NA
Q4.23
NA
NA
vs NA
NA
Q1.24
NA
NA
vs NA
NA
Q2.24
NA
NA
vs NA
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
NA
NA
vs NA
NA
Q1.25
NA
NA
vs NA
NA
Q2.25
NA
NA
vs NA
NA
Q3.25
NA
NA
vs NA
NA
Q4.25
NA
NA
vs NA
NA
Quote Panel
Key Metrics
Forecast
53%2026-Revenue
93%2026-EPS
-53%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(N/A)
Number of analyst
0
Last analyst upgrade/downgrade
Craig-Hallum
initialisePrevious: Not converted
2025-05-05
Now: Buy
Relative Strength
BHST
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
NASDAQ
Unprofitable
Unprofitable
-0.44Â ( -3.98%)
After-hours 11.09$0.47 (4.48%)
Relative Strenght
85
Volume Buzz
15%
Earning Acce
No
Dist 52w H.
17%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How BHST compares to sector?